|
WO2020176863A1
|
|
Thiazole derivatives as protein secretion inhibitors
|
|
AU2019355041A1
|
|
Immunoproteasome inhibitor formulation
|
|
US2021017233A1
|
|
Cdp protein secretion inhibitors
|
|
CN112262129A
|
|
Triazacyclododecane sulfonamide ("TCD") based protein secretion inhibitors
|
|
WO2019060651A1
|
|
Combination therapy for immunological diseases
|
|
WO2019046668A1
|
|
Amide substituted thiazoles as protein secretion inhibitors
|
|
CN111601597A
|
|
Immunoproteasome inhibitors and immunosuppressants in the treatment of autoimmune disorders
|
|
EP3478670A1
|
|
Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
|
|
TW201800397A
|
|
Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof
|
